| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/22/2010 | US7741350 Bicyclic pyrazolo-heterocycles |
| 06/22/2010 | CA2420996C Substituted heterocyclic compounds for treating multidrug resistance |
| 06/22/2010 | CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 06/17/2010 | WO2010066846A2 Method for the isolation of atorvastatin |
| 06/17/2010 | WO2010066658A1 Compounds which potentiate the ampa receptor and uses thereof in medicine |
| 06/17/2010 | WO2010066010A1 Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 06/17/2010 | WO2010027510A3 Enantioselective cascade michael-michael reactions and related catalysts |
| 06/17/2010 | US20100152465 Functionalized Ionic Liquids, and Methods of Use Thereof |
| 06/17/2010 | US20100152464 Synthetic process for aminocyclohexyl ether compounds |
| 06/17/2010 | US20100152463 Methods for Preparing Fluoroalkyl Arylsulfinyl Compounds and Fluorinated Compounds Thereto |
| 06/17/2010 | US20100152462 Process for the preparation of pyrollidine-3-carboxylic acids |
| 06/17/2010 | US20100152274 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester |
| 06/17/2010 | US20100152236 Cyclic amine compound |
| 06/17/2010 | US20100152190 Substituted Pyrrolidine-2-Carboxamides |
| 06/17/2010 | US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 06/17/2010 | US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases |
| 06/17/2010 | US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 06/17/2010 | US20100151388 (Meth)acrylate compound, photosensitive polymer, and resist composition including the same |
| 06/17/2010 | CA2746070A1 Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 06/16/2010 | EP2195293A2 Cycloptopyl amide derivatives |
| 06/16/2010 | EP2195289A2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto |
| 06/16/2010 | EP2195288A2 Small molecule bradykinin b1 receptor antagonists |
| 06/16/2010 | EP1778703B1 Coupling agents comprising a photolabile protecting group and uses thereof, such as for the functionalisation of solid supports |
| 06/16/2010 | CN1921847B Amino alcohol compound |
| 06/16/2010 | CN1910145B Pyrrolidine derivatives acting as CCR3-receptor antagonists |
| 06/16/2010 | CN1771032B Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 06/16/2010 | CN101735137A Method for preparing monoacid imide |
| 06/16/2010 | CN101735134A Chiral 3-hydroxy pyrrolidone compound and preparation method and application thereof |
| 06/16/2010 | CN101735133A Polysubstituted 5-hydroxyl pyrrolones compound and preparation method thereof |
| 06/16/2010 | CN101735132A Synthesis method of N-methyl-2-hydroxyethyl hydroxyethyl |
| 06/16/2010 | CN101298431B One-step synthetic method without solvent of L-pyroglutamine |
| 06/15/2010 | US7737159 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections |
| 06/15/2010 | US7737139 useful in inhibiting the chernotactic activation of neutrophils, induced by the interaction of Interleukin-8 (IL-8) with chemokine membrane receptors |
| 06/15/2010 | US7737135 (2S)-2-[[4'-(methylsulfonyl)-3',5-bis(trifluoromethyl)[1,1'-biphenyl]-2-yl]oxy]-propanoic acid for example; asthma or rhinitis; orphan receptor CRTH2 modulators, prostaglandin D2 is a ligand of CRTH2 |
| 06/15/2010 | US7736396 Hair dyeing composition |
| 06/15/2010 | CA2521647C Novel hydroxamates as therapeutic agents |
| 06/15/2010 | CA2441309C Biguanide derivatives |
| 06/10/2010 | WO2010065841A1 N-substituted pyrrolidonium ionic liquids with expanded linker |
| 06/10/2010 | WO2010065833A2 Functionalized n-substituted pyrrolidonium ionic liquids |
| 06/10/2010 | WO2010065816A1 N-substituted pyrrolidonium ionic liquids |
| 06/10/2010 | WO2010065447A2 Novel compounds |
| 06/10/2010 | WO2010063774A1 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics |
| 06/10/2010 | WO2010063617A1 Mixtures of itaconic acid or itaconic acid derivatives and primary amines for producing 1,3- and 1,4-alkyl methyl pyrrolidones |
| 06/10/2010 | US20100145074 Functionalized n-substituted pyrrolidonium ionic liquids |
| 06/10/2010 | US20100145073 N-substituted pyrrolidonium ionic liquids |
| 06/10/2010 | US20100145072 Process for Producing Cyclic Compounds |
| 06/10/2010 | US20100145071 Small molecule inhibitors of rotamase enzyme activity |
| 06/10/2010 | US20100145061 N-(1-phenyl-2-arylethyl)-4,5-dihydro-2h-pyrrol-5-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors |
| 06/10/2010 | US20100145048 Compounds for the treatment of inflammatory disorders |
| 06/10/2010 | US20100144829 Novel Receptor Antagonists and Their Methods of Use |
| 06/10/2010 | US20100144828 Caffeoylquinic acid derivatives containing nitrogen, and preparation method, pharmaceutical composition and usage thereof |
| 06/10/2010 | US20100144827 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof |
| 06/10/2010 | US20100144785 Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives |
| 06/10/2010 | US20100144747 1h-quinaz0line-2,4-diones |
| 06/10/2010 | US20100144720 Inhibitors of human tumor-expressed ccxckr2 |
| 06/10/2010 | US20100144588 Proton acceptor iminium/carbocation-type coupling agents |
| 06/10/2010 | US20100143500 Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders |
| 06/10/2010 | CA2745499A1 Peptide therapeutic conjugates and uses thereof |
| 06/10/2010 | CA2744191A1 Novel compounds |
| 06/10/2010 | CA2742709A1 Novel 4- (azacycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics |
| 06/09/2010 | EP2194051A1 Process for preparing compounds useful as intermediates for the preparation of modulators of chemokine receptor activity |
| 06/09/2010 | EP2194041A1 Novel crystal form IX of atorvastatin hemi-calcium and processes for its preparation |
| 06/09/2010 | EP1497273B1 Hydroxamic acid derivatives |
| 06/09/2010 | EP1292308B1 Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 06/09/2010 | CN1939919B Low-toxic and broad-spectrum phthalocyanine bactericide, its production and use |
| 06/09/2010 | CN1914152B New compounds, methods for their preparation and use thereof |
| 06/09/2010 | CN1910174B Indolylmaleimide derivatives |
| 06/09/2010 | CN1910173B Indolylmaleimide derivatives as PKC inhibitors |
| 06/09/2010 | CN1805935B Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor |
| 06/09/2010 | CN101723976A Ionic liquids comprising fluoralkyltriffluoroborate anions |
| 06/09/2010 | CN101723928A Ion liquid and preparation technology thereof |
| 06/09/2010 | CN101723872A Symmetric conjugate of polyamine and pyrrolepolyamide and preparation method thereof |
| 06/09/2010 | CN101723871A Method for preparing 4-hydroxy pyrrolidone-2-acetamide |
| 06/09/2010 | CN101721720A Nitroimidazole-amino acid compound nuclide hypoxic contrast agent and precursor thereof |
| 06/09/2010 | CN101249433B Rare-earth metal oxide/zircite process for preparation of catalysts |
| 06/09/2010 | CN101182308B Imidazole chiral ionic liquids containing double function groups as well as preparation method and uses thereof |
| 06/08/2010 | US7732628 Such as 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]benzaldehyde, 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]acetophenone; for incorporation into oligonucleotides during immobilization and conjugation of biopolymers in solid phase synthesis |
| 06/08/2010 | US7732624 from a liquid phase P comprising the target product X and constituents other than the target product X by cooling suspension crystallization in an indirect heat transferer; target product X in the process is acrylic acid |
| 06/08/2010 | US7732623 Form V, having improved water solubility over Form 1; formed by dissolving a metal, ammonium or alkylammonium salt of atorvastatin in a solvent, contacting with a calcium salt and isolating |
| 06/08/2010 | US7732482 mycelium extracts such as 3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]furan-2,5-dione, that inhibits beta-transforming growth factor mediated inflammation and fibrosis |
| 06/08/2010 | US7732481 Prolinylarylacetamides |
| 06/08/2010 | CA2564030C Salt forms of [r-(r*, r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid |
| 06/08/2010 | CA2433039C Agent for therapeutic and prophylactic treatment of neuropathic pain |
| 06/03/2010 | WO2010061025A1 Functionalization of 1-vinyl-2-pyrrolidone at position 3, comprising the opening of cyclic precursors |
| 06/03/2010 | WO2010060801A1 Process for removing by-products from n-vinylamides |
| 06/03/2010 | WO2010060703A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
| 06/03/2010 | US20100137599 Process for preparing 1,4-butandiol monitrate |
| 06/03/2010 | US20100137595 Vaginal odorants |
| 06/03/2010 | US20100137583 Peptidomimetic protease inhibitors |
| 06/03/2010 | US20100137400 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 06/03/2010 | US20100137365 Long chain N-alkyl compounds and oxa-derivatives thereof |
| 06/03/2010 | US20100137229 Method Of Enhancing Lysosomal Alpha-Galactosidase A |
| 06/03/2010 | US20100137173 Pyrrolidine-2,5-dione derivatives for use in friction modification |
| 06/03/2010 | CA2742463A1 3-(benzylamin0)-pyrr0lidine derivatives and their use as nk-3 receptor antagonists |
| 06/02/2010 | EP2192113A1 Novel crystal form XI of atorvastatin hemi-calcium and processes for its preparation |
| 06/02/2010 | EP2192112A1 Process for preparing atorvastatin hemi-calcium Form I |
| 06/02/2010 | EP2190815A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 06/02/2010 | EP1658263B1 Novel aminobenzophenone compounds |
| 06/02/2010 | EP1517881B1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 06/02/2010 | EP1483228B1 Nk1 antagonists |